Tom Beck

Biography

 Tom Beck, M.D. is an Executive Partner at F-Prime Capital. Most recently, Dr. Beck served as President, Chief Operating Officer at Dyax Corp. Prior to that, he held positions at UCB Pharma (Corporate Vice President, Director of Global Research and Development), CytoMed, Inc. (Chairman and Chief Executive Officer) and Enzytech Inc. (President). He began his industry career at Smith Kline and French, and held positions in both clinical and business development. Dr. Beck currently serves on the boards of Mersana Therapeutics, Adagene Inc., and Dimension Therapeutics (where he is currently Chief Executive Officer), and is an observer to the boards of Aclaris Inc. and Rugen Therapeutics. Previously, he served on the boards of Neurotherapeutics Pharma, Vicept Inc., and Topaz Inc. (where he also served as Chief Executive Officer). Dr. Beck is board-certified in internal medicine and nephrology and was Assistant Professor of Medicine at Temple University School of Medicine. He received his Bachelor of Science degree from Yale University and his medical degree from Cornell University

Research Interest

 Pharmaceutical Science